← Every firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories) FDA Recalls
2 recalls on file across drugs, 0 of them Class I and 0 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 CapsClass IIApr 1, 2022Failed Impurities/Degradation Specifications: OOS result was |
| Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 CapsClass IIApr 1, 2022Failed Impurities/Degradation Specifications: OOS result was |